Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia. CAR T-cell therapy is a unique way of treating hematologic ...

UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

Dr. Matthew Ku discusses what CAR T-cell therapy is and how it works to target diseases like myelofibrosis. T cells are a natural part of the immune system designed to fight infections and cancer, but ...

A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and ...

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...

In a move that could dramatically expand access to a revolutionary new treatment, the Food and Drug Administration (FDA) has eliminated some of the safety restrictions for CAR T-cell therapies. This ...